Transient modulation of E-cadherin-mediated cell-cell adhesion may improve paracellular drug delivery through biological barriers. Therefore, there is a need to develop an efficient method to evaluate cadherin peptides that can modulate the intercellular junctions. The objective of this study was to establish a novel assay to evaluate peptide activity in modulating E-cadherin-mediated homophilic interactions, based on the homotypic adhesion of Caco-2 cells. Fluorescence-labeled Caco-2 single cells were incubated with Caco-2 monolayers that were treated beforehand with Ca 2ϩ -free medium. The homotypic adhesion in the presence or absence of peptide and antibody was determined fluorometrically. The Ca 2ϩ -deficient pretreatment dramatically increased the number of single cells bound to the monolayers. Immunofluorescence staining showed that some of E-cadherins became accessible without surfactant-induced permeabilization of Caco-2 cell monolayers after the Ca 2ϩ -deficient pretreatment. The homotypic adhesion was largely dependent on extracellular Ca 2ϩ concentrations and significantly inhibited by the presence of anti-E-cadherin monoclonal antibody DECMA-1. In contrast, DECMA-1 did not inhibit E-cadherin-independent adhesion, such as the homotypic adhesion of Caco-2 cells in the absence of Ca 2ϩ or the heterotypic adhesion of Molt-3 T cells to Caco-2 monolayers. These results indicate the predominant involvement of E-cadherin-mediated cell-cell adhesion in this assay. E-cadherinderived peptides, which had been shown in our previous studies to inhibit E-cadherin-mediated cell-cell adhesion, significantly inhibited homotypic adhesion in a dose-dependent manner. These results, taken together, suggest that the present assay can be used for evaluation of peptide, protein, or antibody activity in modulating the E-cadherin-mediated homophilic interactions in the context of whole live cells.
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Cadherins are Ca 2ϩ -dependent adhesion molecules that mediate cell-cell contact in biological barriers such as the intestinal mucosa and blood-brain barrier. Cadherins are also essential for embryonic development, tissue morphogenesis, and cellular processes and functions (Takeichi, 1990 (Takeichi, , 1991 Gumbiner, 1996) . In the epithelial layer, E-cadherins reside at the adherens junctions between tight junctions and desmosomes. The formation and maintenance of the tight junctions are influenced by the integrity of the adherens junctions (Takeichi, 1991) . The opening and resealing of the tight junctions can be controlled by removing and restoring the extracellular Ca 2ϩ (Gumbiner and Simons, 1986; Cereijido et al., 2000) . This is presumably due to modulation of E-cadherin-mediated cell-cell adhesion at the junctions of the adherens. Ca 2ϩ ions are necessary for the adhesive function of E-cadherin. Thus, E-cadherin has a key role in controlling the integrity of intestinal mucosa epithelium.
E-cadherin is a transmembrane glycoprotein that consists of an extracellular domain with five homologous repeats (EC1-5), a single transmembrane region, and a highly conserved cytoplasmic tail. The extracellular domains play important roles in organizing cadherin homophilic interactions and determining the specificity of cell-cell adhesion (Nose et al., 1990; Takeichi, 1990) . EC1 and EC2 domains of cadherins have been studied extensively for their role in cell-cell adhesion (Nose et al., 1990; Shapiro et al., 1995; Nagar et al., 1996; Pertz et al., 1999; Shan et al., 2004) . It has been suggested that a conserved His-Ala-Val (HAV) sequence found in the EC1 domain may be important for cadherin-cadherin interaction. Synthetic peptides containing an HAV sequence can interfere with cadherin-mediated cell-cell adhesion (Blaschuk et al., 1990a,b; Noe et al., 1999; Williams et al., 2000) . We have shown that HAV peptides from EC1 of E-cadherin can effectively inhibit E-cadherin-mediated aggregation of bovine brain microvessel endothelial cells (BBMECs) (Lutz and Siahaan, 1997; Pal et al., 1997) and increase the paracellular porosity of Madin-Darby canine kidney (MDCK) cell monolayers (Makagiansar et al., 2001; Sinaga et al., 2002) . Recent studies indicate that the trans-interactions between cadherins of opposing cells involve not only EC1-to-EC1 interaction but also interactions of multiple domains (Leckband and Sivasankar, 2000; ChappuisFlament et al., 2001; Perret et al., 2004) . Despite numerous studies to elucidate the mechanisms of E-cadherinmediated cell-cell adhesion, the organization of E-cadherin interactions still remains unclear. The functions of each domain in the formation of cell-cell contact need further investigation.
One way to elucidate the mechanisms of E-cadherin-mediated cell-cell adhesion is by using peptides that are derived from E-cadherin sequence. The E-cadherin peptides can be used to evaluate the important regions of E-cadherin. Furthermore, peptides that can modulate E-cadherin-mediated cell adhesion may have potential application for modulation of the intercellular junctions of the biological barrier to improve permeation of large hydrophilic drugs via the paracellular pathway. Thus, there is a need to develop an assay that can be used to evaluate E-cadherin peptide in blocking cadherin-cadherin interactions. To date, there are a limited number of assays available to evaluate peptide activities in the context of whole live cells. One of these is measuring the transepithelial electrical resistance (TEER) or paracellular permeation of marker molecules of the cell monolayer upon modulation with peptides (Makagiansar et al., 2001; Sinaga et al., 2002) . Although this method is well established, it is a time-consuming process to establish tight monolayers. In addition, due to the limited pore size (Ͻ11Å) of the tight junctions (Adson et al., 1994) , there is a size limit for Ecadherin peptides that can be used. Thus, larger cadherin peptides (i.e., 10 -24 amino acids) have difficulty in penetrating the tight junctions to reach the adherens junctions. Another method is the cell aggregation assay in which the extent of aggregation of single cells is evaluated as a function of inhibitor concentrations (Lutz and Siahaan, 1997; Pal et al., 1997; Noe et al., 1999; Renaud-Young and Gallin, 2002; Shan et al., 2004) . Unfortunately, it is difficult to quantitate the effect of the peptides in inhibiting the E-cadherin-mediated cell adhesion in this assay.
Therefore, in the present study, we attempted to develop a novel adhesion assay to evaluate the activities of various compounds, including proteins, peptides, and peptidomimetics, in modulating E-cadherin-mediated cell-cell interactions. The assay is based on the homotypic adhesion of Caco-2 single cells to tissue culture plate-associated Caco-2 cells (i.e., attached cells). We found that the homotypic adhesion of Caco-2 cells was predominantly mediated by E-cadherin, by which the peptide activities in modulating the human Ecadherin-mediated cell-cell interactions can be evaluated in the context of live cells.
Materials and Methods

Cell Cultures
Human colon carcinoma cells (Caco-2) obtained from American Type Culture Collection (Manassas, VA) were cultured in Dulbecco's modified Eagle's medium (DMEM; Sigma-Aldrich, St. Louis, MO) containing 4 mM L-glutamine, 4500 mg/l glucose, 110 mg/l sodium pyruvate, 3.7 g/l NaHCO 3 , 5 mM HEPES-Na, 0.1 mM nonessential amino acids, 100 units/ml penicillin, 100 g/ml streptomycin, and 10% fetal bovine serum (FBS; Invitrogen, Carlsbad, CA). Molt-3 human lymphoblastic T cells obtained from American Type Culture Collection were cultured in RPMI 1640 (Sigma-Aldrich) containing 2 mM L-glutamine, 2000 mg/l glucose, 2 g/l NaHCO 3 , 10 mM HEPESNa, 100 units/ml penicillin, 100 g/ml streptomycin, and 10% FBS. Cells were grown and maintained in a 75-cm 2 tissue culture-treated flask (BD Biosciences, San Jose, CA) in 5% CO 2 atmosphere of 95% relative humidity at 37°C.
Peptides
E-cadherin-derived peptides were synthesized with 9-fluorenylmethyloxycarbonyl-protected amino acid chemistry on 9-fluorenylmethyloxycarbonyl-PAL-PEG-PS resin (Applied Biosystems, Foster City, CA) using the automated peptide synthesis system (Pioneer; PerSeptive Biosystems, Framingham, MA). Cleavage of the peptides from the resin and removal of the protecting groups from the side chain were carried out using trifluoroacetic acid with appropriate scavengers. The crude peptides were purified by reversed-phase high-performance liquid chromatography using a C 18 column with a gradient of solvent A [95%/5% ϭ H 2 O (0.1% trifluoroacetic acid/ acetonitrile)] and solvent B (100% acetonitrile). The purity of the peptide was analyzed by analytical high-performance liquid chromatography using an analytical C 18 column. The identity of the synthe- 
Antibodies
Some of the antibodies were purchased from Sigma-Aldrich, including antiuvomorulin/E-cadherin monoclonal antibody (mAb) (clone DECMA-1), anti-pan cadherin mAb (clone CH-19), purified mouse IgG isolated from pooled normal mouse serum, and goat anti-mouse IgG (Fc-specific)-FITC antibody. Other antibodies were purchased from different vendors, including: mouse anti-human Ecadherin mAb (clone SHE78-7) from EMD Biosciences (San Diego, CA) and goat anti-N-cadherin polycolonal antibody (N-19) from Santa Cruz Biotechnologies (Santa Cruz, CA). DECMA-1 and SHE78-7 were used for inhibition of E-cadherin-mediated homotypic adhesion and for immunostaining of E-cadherin, respectively. CH-19 and mouse IgG were used as negative controls.
Homotypic Adhesion of Caco-2 Single Cells to Attached Cells
Preparation of Caco-2 Single-Cell Suspension. Caco-2 cells were cultured in 10% FBS-DMEM in a tissue culture flask. Highly confluent monolayers were avoided because it is difficult to prepare single-cell suspensions. After washing with HBSS(Ϫ) (i.e., HBSS without Ca 2ϩ and Mg 2ϩ ), the cells were treated with 2.5 mM EDTA in PBS for 1 to 2 min at room temperature (RT) to remove excess divalent cations. Then, the cells were washed with HBSS(Ϫ) to remove remaining EDTA and incubated with Ca 2ϩ -and Mg 2ϩ -free Earle's balanced salt solution (EBSS) for 1 h at 37°C in 5% CO 2 . Within 1 h, most of the cells were detached from the culture flask. For fluorescence labeling, the detached cells were incubated in 10 ml of solution of 2Ј,7Ј-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF) acetoxymethyl ester (AM; Invitrogen) with gentle shaking for 45 min at 37°C. The BCECF-AM solution was prepared by dissolving 50 g of BCECF-AM in 50 l of dimethyl sulfoxide followed by dilution to 10 ml with 0.1% BSA-containing DMEM. Long incubation was avoided because the amount of intracellular BCECF declined after incubation times of more than 45 min. The free BCECF was washed from the cell suspension three times with icecold PBS(Ϫ) (i.e., PBS without Ca 2ϩ and Mg 2ϩ ). The BCECF-labeled cells were resuspended in 0.1% BSA-DMEM at a density of 5 ϫ 10 5 cells/ml. The cell suspension and inhibitor solutions were mixed in equal volumes. Due to this dilution, the inhibitor solution was prepared in a concentration that was twice the final concentration after mixing with the cells. For Ca 2ϩ -deficient samples, the BCECF-labeled Caco-2 single cells were suspended in Ca 2ϩ -free and 0.8 mM Mg 2ϩ -containing 0.1% BSA-EBSS at a density of 2.5 ϫ 10 5 cells/ml. These single cells were added to the attached cells (see below) for evaluation of the cell adhesion properties.
Adhesion of Caco-2 Single Cells and Attached Cells. Confluent Caco-2 cell monolayers were cultured in 10% FBS-DMEM in 48-well tissue culture-treated microplates (Corning, Acton, MA). The cell monolayers were washed twice with PBS(Ϫ) and then subjected to "Ca 2ϩ -deficient pretreatment" procedure to produce a cell layer called "attached cells." The Ca 2ϩ -deficient pretreatment procedure was done by incubating the monolayers in Ca 2ϩ -free PBS or EBSS (1 mM Mg 2ϩ , 0.1% BSA) for 2 h at 37°C in 5% CO 2 . After removing the pretreatment medium, the attached cells were incubated with 200 l/well BCECF-labeled Caco-2 single-cell suspensions (5 ϫ 10 4 cells/ well) containing certain concentrations of antibodies or peptides. This mixture was incubated for 2 h (unless otherwise mentioned) at 37°C in 5% CO 2 .
To remove the unbound cells, the culture plates were flipped and softly tapped against a paper towel several times. To wash the remaining unbound cells, 500 l of ice-cold PBS(ϩ) (i.e., PBS containing 1 mM Ca 2ϩ , 1 mM Mg 2ϩ , and 0.1% D-glucose) was added to each well followed by flipping and softly tapping the plates; this procedure was repeated three times. We found that this washing procedure is crucial to distinguish the Ca 2ϩ -dependent cell adhesion from apparent adhesion at 0 mM Ca 2ϩ . In fact, we found that the use of a suction pump to remove the solution with unbound single cells leaves a significant amount of unbound cells in the wells (data not shown).
Then, 400 l of lysis buffer (0.5% Triton X-100 and 2 mM EDTA in 0.1 M CHES, pH 9.5) was added to each well and incubated for 1 h at 37°C with gentle shaking. The solution from each well was subjected to centrifugation to remove the cell debris, and 150 l of the supernatant was transferred to 96-well flat clear bottom (black) microplates (Corning). The fluorescence intensity of each well was measured in duplicate using a microplate fluorescence analyzer (BioTek FL600) at excitation of 485 nm and emission of 530 nm. The fluorescence intensity was correlated with the number of bound cells using a standardization procedure given below.
Calibration of Fluorescence Intensity versus Cell Number. Because BCECF is a known substrate for multidrug resistanceassociated protein (Draper et al., 1997; Bachmeier et al., 2004) , the amount of BCECF in the cells decreases upon longer incubation time at 37°C. To calibrate the cell-associated fluorescence intensity at the duration of incubation, we separately measured the amount of BCECF remaining in the single cells versus incubation time. Based on these data, the fluorescence intensity was corrected for each cell adhesion experiment. The number of adherent cells (percentage of applied cells) was calculated using the amount of fluorescence from a determined number of cells. The data were also presented as Ca 2ϩ -dependent adhesion; this was calculated by subtracting the data obtained from cell adhesion in the absence of Ca 2ϩ . The relative activity of each peptide can be compared using a standard mAb DECMA-1; this mAb inhibits approximately 60% of Ca 2ϩ -dependent adhesion at 1:100 dilution of mAb concentration.
Heterotypic Adhesion of Molt-3 T Cells to Attached Caco-2 Cells
Heterotypic adhesion of Molt-3 human lymphoblastic T cells to Caco-2 cells was performed as described above with some modifications (Yusuf-Makagiansar et al., 2001a,b) . In brief, Molt-3 T cells were activated with 0.2 M phorbol 12-myristate 13-acetate (SigmaAldrich) for 16 h at 37°C in 5% CO 2 before BCECF labeling. Caco-2 cell monolayers were incubated in 10% FBS-DMEM containing 100 IU/ml interferon-␥ (BD Biosciences) for 14 h at 37°C in 5% CO 2 and then subjected to Ca 2ϩ -deficient pretreatment in PBS containing 0.1% BSA, 1 mM Mg 2ϩ , and 100 IU/ml interferon-␥ for an additional 2 h. BCECF-labeled Molt-3 T cell suspensions (1 ϫ 10 6 cells/ml in 0.1% BSA-RPMI 1640) were added (200 l/well) to the attached Caco-2 cells and incubated in the presence or absence of mAb for 2 h at 37°C in 5% CO 2 . The washing procedure and determination of the number of adhesive cells were accomplished as described above.
Immunofluorescence Staining
Confluent Caco-2 cell monolayers were washed three times with PBS(ϩ) and fixed in 4% formaldehyde for 20 min at RT. Some were then permeabilized with 0.5% Triton-X-100/PBS(ϩ) for 15 min at 37°C. After blocking with 1% BSA-and 5% skim milk-containing PBS(ϩ) (blocking buffer) for 60 min at RT, the cells were incubated with the primary antibody SHE78-7 (2 g/ml in blocking buffer) for 60 min at 37°C. The cells were washed three times with 0.05% Tween 20-containing PBS and then were incubated with FITC-labeled goat anti-mouse IgG for 60 min at 37°C. The cells were washed three times with 0.05% Tween 20-containing PBS to remove the excess antibodies. The fluorescence was observed under a fluorescence microscope (Nikon, Tokyo, Japan) equipped with Flash Point software.
Results
Caco-2 Single-Cell Adhesion to Caco-2-Modified Monolayers. In a confluent monolayer, E-cadherins are abundant and localized at the adherens junctions below the tight junctions. However, E-cadherins are not exposed to the surface of cell monolayer and are not available for homophilic binding with E-cadherins from Caco-2 single cells for cell-cell adhesion. To solve this problem, we first evaluated a treatment of the Caco-2 cell monolayers with Ca 2ϩ -deficient medium to relocalize some of the E-cadherins from the adherens junctions to the cell surface. These treated monolayers will be called Caco-2 attached cells since most of the cells are slightly retracted from the neighboring cells after Ca 2ϩ -deficient pretreatment and, thus, are no longer true monolayers. Previously, deletion of the extracellular Ca 2ϩ has been shown to disrupt the E-cadherin-E-cadherin interactions in the adherens junction and internalize the E-cadherins followed by recycling to the surface of cell monolayers (Kartenbeck et al., 1982 (Kartenbeck et al., , 1991 Le et al., 1999) . Addition of Caco-2 single cells to the Caco-2 attached cells showed strong homotypic cell-cell adhesion compared with untreated Caco-2 cell monolayers (Fig. 1) . The extent of homotypic adhesion was influenced by the duration of treatment of Caco-2 cell monolayers with Ca 2ϩ -deficient medium. The homotypic adhesion was enhanced by increasing the pretreatment time of the confluent monolayers; the increase in cell-cell adhesion reached a plateau at pretreatment times beyond 2 h. Thus, 2-h pretreatment was used throughout this study.
To examine whether the enhanced adhesion was attributable to the relocalization of E-cadherins to the surface of Caco-2 attached cells, immunostaining experiments with anti-E-cadherin mAb SHE78-7 were carried out to detect the Downloaded from E-cadherins. Strong fluorescence signals were found at the intercellular junctions of confluent Caco-2 cell monolayers that were permeabilized with Triton X-100 ( Fig. 2A) . On the other hand, very few fluorescence signals were observed on the nonpermeabilized monolayers (Fig. 2B) . Finally, the Caco-2 attached cells that were previously treated with Ca 2ϩ -deficient medium showed significant amounts of fluorescence signals, suggesting the relocalization of E-cadherin to the cell surface (Fig. 2C) . As a negative control, purified mouse IgG was used instead of anti-E-cadherin mAb, and there was no detectable decoration of the cells (Fig. 2D) . The results from immunostaining and cell adhesion assay suggest the relocalization of E-cadherins to the cell surface of Caco-2 attached cells by the Ca 2ϩ -deficient pretreatment. Next, we examined the effect of incubation time on Caco-2 single-cell adhesion to treated or untreated cells (Fig. 3) . In this experiment, the effect of BCECF efflux (Draper et al., 1997; Bachmeier et al., 2004) has been compensated as described under Materials and Methods. In general, the number of adherent single cells increased with time of incubation. However, the treated Caco-2 cells have stronger adhesion properties than those of untreated monolayers. The singlecell adhesion was rapidly increased between 0 to 4 h incubation time and plateaued between 4 to 8 h incubation time. This result is consistent with the relocalization of E-cadherins to the cell surface of Caco-2 attached cells. Because the efflux of BCECF was very apparent between 4-and 8-h time points (data not shown), we used 2-h incubation time for evaluating the effect of E-cadherin peptides on the single-cell adhesion.
Involvement of E-Cadherin in Caco-2 Single-Cell Adhesion to Attached Cells. To confirm the involvement of E-cadherin in the Caco-2 single-cell adhesion to attached cells, the effect of Ca 2ϩ concentration on the magnitude of cell-cell adhesion was evaluated (Fig. 4) . In this experiment, EBSS with various concentrations of Ca 2ϩ (0 -2 mM) was used instead of DMEM containing 1.8 mM Ca 2ϩ . Our preliminary evaluation showed that EBSS supplemented with 0.8 mM Mg 2ϩ and 1.8 mM Ca 2ϩ produced an extent of cell adhesion similar to that with DMEM (data not shown). This result confirms that the difference in composition other than Ca 2ϩ in EBSS and DMEM does not significantly influence the cell adhesion properties. The number of adherent cells was largely dependent on the Ca 2ϩ concentrations and was increased at higher Ca 2ϩ concentration. These results indicate that the homotypic cell adhesion process uses Ca 2ϩ -dependent mechanisms, which are normally mediated by E-cadherin homophilic interactions.
To specify the involvement of E-cadherin in the cell adhesion process, we investigated the effect of anti-E-cadherin mAb DECMA-1 in blocking Caco-2 single-cell adhesion to the attached cells (Fig. 5) . It is interesting to find that DECMA-1 mAb effectively blocked the homotypic cell adhesion in a concentration-dependent manner because this mAb binds to the extracellular domain of E-cadherin. In contrast, CH-19 mAb did not inhibit the cell adhesion because this mAb binds to the cytoplasmic C-terminal domain of E-cadherin. Furthermore, anti-N-cadherin polycolonal antibody N-19 could not interfere with the adhesion (data not shown), suggesting that the adhesion process is not mediated by N-cadherin. Although Caco-2 cells have N-cadherin , the results indicate that the cell-cell adhesion process is predominantly mediated by E-cadherin homophilic interactions.
To further confirm the involvement of E-cadherin in the cell adhesion process, the effect of extracellular Ca 2ϩ concentrations on the inhibitory effect of DECMA-1 mAb was examined (Fig. 6A ). In addition, the heterotypic adhesion of Molt-3 human lymphoblastic T cells to the Caco-2 attached cells was examined (Fig. 6B) . As expected, the homotypic adhesion of Caco-2 cells was significantly inhibited by DECMA-1 mAb at Ca 2ϩ concentration of 1.8 mM. However, DECMA-1 could not inhibit the E-cadherin-mediated cell adhesion in the absence of Ca 2ϩ . The heterotypic adhesion of Molt-3 T cells to the Caco-2 attached cells was not inhibited by DECMA-1 mAb, suggesting that this heterotypic cell adhesion was not mediated by E-cadherin. Molt-3 T cells have been shown to express N-cadherin but not E-cadherin . These results support the idea that the homotypic adhesion of Caco-2 single cells to attached cells is mediated mainly by E-cadherin homophilic interactions.
Inhibition of Cell-Cell Adhesion by HAV Peptides. HAV peptides were also used to inhibit the Caco-2 single-cell adhesion to attached cells. HAV peptides were derived from the conserved HAV motif at the EC1 domain of E-cadherin. Previously, we have shown that these peptides block E-cadherin-mediated cell-cell adhesion of BBMEC and MDCK cells (Lutz and Siahaan, 1997; Pal et al., 1997; Makagiansar et al., 2001; Sinaga et al., 2002) . The long HAV24 and HAV10 peptides showed significant and dose-dependent inhibitory activities to almost the same extent as DECMA-1 mAb (Fig.  7B ). On the other hand, the shorter hexapeptides (SHAVSS, SHAVAS, and SHAASS) did not inhibit the Caco-2 single-cell adhesion (Fig. 7, A and B) . The hexapeptides SHAVSS and SHAVAS have also been shown to modulate the intercellular junctions of the MDCK cell monolayers (Makagiansar et al., 2001) . These results suggest that the longer HAV peptides bind to E-cadherins and block the E-cadherin-mediated cellcell adhesion. Furthermore, this assay can be used to evaluate molecules (peptides, protein, and small molecules) that modulate E-cadherin-mediated cell-cell adhesion.
Discussion
Modulation of E-cadherin-mediated cell-cell adhesion may have implications for improving drug delivery through the paracellular pathway of biological barriers (i.e., intestinal mucosa and blood-brain barrier) and understanding the mechanism of cadherin-mediated interactions in the intercel- Fig. 5 . Inhibitory effect of anti-E-cadherin mAb DECMA-1 on the Caco-2 single-cell adhesion to attached cells. Caco-2 cell monolayers were incubated in Ca 2ϩ -free EBBS for 2 h. Then, BCECF-labeled Caco-2 single cells were added and incubated for adhesion for 2 h in the presence or absence of mAb (DECMA-1 or anti-pan cadherin CH-19). The results are expressed as the mean Ϯ S.D. (n Ն 3). Significant differences versus control (without mAb); ‫,ءء‬ P Ͻ 0.01. Fig. 6 . A, effect of anti-E-cadherin mAb DECMA-1 on the homotypic adhesion of Caco-2 single cells to attached cells. Caco-2 cell monolayers were incubated in Ca 2ϩ -free EBBS for 2 h. Then, BCECF-labeled Caco-2 single cells were added and incubated for adhesion for 2 h in 0.1% BSA-EBSS containing Mg 2ϩ (0.8 mM) and Ca 2ϩ (1.8 or 0 mM) in the presence or absence of mAb. Black bar, control (without mAb); white bar, DECMA-1 (1:100); gray bar, DECMA-1 (1:400). B, effect of anti-E-cadherin mAb DECMA-1 on the heterotypic adhesion of Molt-3 T cells to Caco-2 attached cells. Caco-2 cell monolayers were activated with interferon-␥ overnight and then pretreated with Ca 2ϩ -free EBBS containing interferon-␥ for 2 h. BCECF-labeled, phorbol 12-myristate 13-acetateactivated Molt-3 T cells were added and incubated for 2 h in 0.1% BSA-RPMI 1640 in the presence or absence of mAb. The results are expressed as the mean Ϯ S.D. (n Ն 3). Significant differences versus corresponding control (without mAb); ‫,ءء‬ P Ͻ 0.01. jpet.aspetjournals.org lular junctions. Several different assays have been developed to evaluate the effect of molecules to modulate E-cadherinmediated cell-cell adhesion. However, some of these assays have drawbacks in evaluating the inhibitory activity of compounds of interest, especially proteins, peptides, or antibodies, that block E-cadherin-mediated cell-cell adhesion. For example, classic cell aggregation assay has been used to characterize Ca 2ϩ -dependent cell-cell adhesion; however, it is difficult to get a quantitative concentration-dependent activity of the inhibitors. We also have used TEER measurements of cell monolayers to evaluate the activity of E-cadherin peptides in modulating E-cadherin homophilic interactions. Unfortunately, this assay is time-consuming and is only applicable to a small peptide that has a hydrodynamic radius Ͻ 11Å; this is due to the presence of tight junctions. To discover a new "lead" peptide(s) from different regions of E-cadherin, larger peptides (i.e., 25 amino acids) with overlapping sequences need to be evaluated; however, these large peptides will not penetrate the tight junction and modulate E-cadherin interaction in the traditional assays. Therefore, there is a need to develop a fast and quantitative assay for evaluating the activity of larger peptide inhibitors of E-cadherin-mediated cell-cell adhesion. Once a large lead peptide is found using this new cell-cell adhesion assay, this large peptide will be reduced to hexapeptides with overlapping sequences to evaluate the active sequence(s) that can be tested in traditional monolayer assay. Here, we have developed a novel adhesion assay for evaluating molecules that block the E-cadherin-mediated cell-cell adhesion. This would provide an advantage over conventional methods by overcoming the size limitation problems as well as the time-consuming process. Yet, a potent candidate found in this adhesion assay might not work as the modulator of paracellular pathway in vivo since the biological barriers can function as cell monolayers. Thus, assays that maintain intact tight junctions may be necessary following an efficient screening of potential candidates based on the present assay.
The assay involves E-cadherin-mediated homotypic adhesion of Caco-2 single cells to Caco-2 attached cells. The attached cells were derived from Caco-2 cell monolayers that were treated by extracellular Ca 2ϩ depletion. This pretreatment produces partial relocalization of E-cadherins from the intercellular junctions to the cell surface without detaching the cells from the plate. Our hypothesis is that incubation of Caco-2 cell monolayers with Ca 2ϩ -free medium would disrupt the Ca 2ϩ -dependent E-cadherin homophilic interaction at the adherens junction; this disruption would be followed by internalization and recycling of E-cadherins to the cell membrane (Kartenbeck et al., 1982 (Kartenbeck et al., , 1991 Le et al., 1999) . Thereby, some of E-cadherins would be redistributed to the cell surface of the attached cells and become accessible for binding with E-cadherins from Caco-2 single cells. It should be noted that we could not exclude the possibility that the tight junctions were disrupted by the treatment with Ca 2ϩ -deficient medium, and this may allow access of the primary antibody to the intracellular space between the cells. Mg 2ϩ ions were included in the pretreatment medium to prevent the release of the attached cells from the plate; this is based on the fact that divalent cations are required for cell attachment to the plate via integrin-extracellular matrix adhesion process. The redistribution of the E-cadherins was evident from the E-cadherin immunolocalization study using anti-Ecadherin mAb (Fig. 2) . Addition of Caco-2 single cells to the attached cells produced Ca 2ϩ -dependent cell-cell adhesion. The unbound single cells can be washed out to determine the amount of bound single cells. The rate and amount of the single-cell adhesion are dependent on the duration of pretreatment of the cell monolayer with Ca 2ϩ -deficient medium (Figs. 1 and 3) . The single-cell adhesion can be inhibited by anti-E-cadherin mAb (DECMA-1) to the extracellular domain but not mAb to the cytoplasmic domain (Fig. 5) . The antibody inhibition of cell adhesion was also dependent on Ca 2ϩ concentration (Fig. 6A) . These results suggest that the homotypic adhesion of Caco-2 single cells to the attached cells is predominantly mediated by E-cadherins. Ca 2ϩ ions have an essential role to provide rigidity to the extracellular domain of E-cadherin to form a rod-like conformation (Pokutta et al., 1994; Nagar et al., 1996) . This rod-like structure is crucial for the adhesive functions of cadherins (Ozawa et al., 1990; Takeichi, 1991; Pokutta et al., 1994; Pertz et al., 1999) . E-cadherins of a cell form a lateral dimer (cis-dimer) at the extracellular domain before the cis-dimers from opposing cells form trans-oligomers that are responsible for cell-cell adhesion (Brieher et al., 1996; Yap et al., 1997; Takeda et al., 1999; Ozawa, 2002) . Pertz et al. (1999) have demonstrated that the cis-and trans-dimer formations of the EC1-EC2 domain of E-cadherin were observed at Ca 2ϩ concentrations of 50 to 1000 M and Ͼ1000 M, respectively. This is consistent with our current assay, in which the homotypic adhesion of Caco-2 single cells to attached cells is Ca 2ϩ -dependent (Fig. 4) . There is some extent of cell adhesion in the absence of Ca 2ϩ , the level of which varies in each experiment probably depending on the efficacy of Ca 2ϩ -deficient pretreatment and the extent of washing process. The presence of cell adhesion in the absence of Ca 2ϩ may be due to the Ca 2ϩ -independent cell-cell adhesion, presumably mediated by Ca 2ϩ -independent cell adhesion molecules such as nectins (Shimizu and Takai, 2003) or integrins. The Ca 2ϩ -dependent homotypic cell adhesion was significantly inhibited by anti-E-cadherin mAb DECMA-1 in a concentrationdependent manner; however, DECMA-1 mAb could not completely inhibit the Ca 2ϩ -dependent adhesion. This is presumably due to the presence of other Ca 2ϩ -dependent cell adhesion molecules such as desmogleins and desmocollins (Burdett, 1998; Garrod et al., 2002) . It was interesting to find that DECMA-1 mAb did not block the homotypic adhesion of Caco-2 cells in Ca 2ϩ -free medium where E-cadherins did not form trans-oligomers (Ozawa et al., 1990; Takeichi, 1991; Pokutta et al., 1994; Pertz et al., 1999) and the heterotypic adhesion of Molt-3 T cells to Caco-2 attached cells; Molt-3 T cells did not express E-cadherin (Fig. 6 ). Taken together, these results suggest that the major contribution for the cell adhesion process in this assay is the E-cadherin homophilic interactions. Therefore, this assay was used to evaluate the activity of E-cadherin peptides.
In this assay, HAV peptides were used to inhibit the homotypic adhesion of Caco-2 single cells to attached cells. HAV peptides had been shown to inhibit E-cadherin-mediated aggregation of BBMEC (Lutz and Siahaan, 1997; Pal et al., 1997) and to increase paracellular porosity of MDCK cell monolayers (Makagiansar et al., 2001; Sinaga et al., 2002) . We also have discovered ADT peptides from another region of EC1 domain, called a bulge region, that can modulate E-cadherin-mediated cell-cell adhesion in MDCK cell layers (Sinaga et al., 2002) . Consistent with our previous studies, HAV10 and HAV24 peptides inhibited homotypic Caco-2 cell adhesion in a dose-dependent manner (Fig. 7) . As in our BBMEC aggregation assay (Lutz and Siahaan, 1997) , HAV24 peptide was more potent than HAV10 peptide in the present assay. This may be due to the propensity to preserve the conformation of the HAV motif in longer peptides (HAV24) than in smaller peptides (HAV10). Although hexapeptides SHAVSS and SHAVAS could lower the TEER values of MDCK cell monolayers (Makagiansar et al., 2001; Sinaga et al., 2002) , they did not block the E-cadherin-mediated homotypic adhesion of Caco-2 cells in this study (Fig. 7) . In our recent study, these hexapeptides could not modulate the paracellular porosity of Caco-2 cell monolayers nor block the resealing of intercellular junctions loosened by EDTA chelation (A. Calcagno and T. J. Siahaan, unpublished data). This could be due to several factors. First, the hexapeptides may not maintain the active conformation of the HAV motif; thus, they have a low binding selectivity for E-cadherin. Second, there is a possibility of subtle differences in E-cadherin in MDCK and Caco-2 cells that contributes to the binding properties between the hexapeptides and E-cadherin. In the present assay, peptides had free access to the E-cadherin-E-cadherin interaction sites between the single cells and the attached cells. Thus, the different activity of the same HAV hexapeptides in Caco-2 cells and MDCK cells is likely not due to the limited accessibility of peptides to the binding sites but probably to the species differences in binding selectivity of E-cadherin. We have shown that the HAV sequence and its flanking residues are important for the binding selectivity of HAV-peptides Siahaan, 1995, 1997; Pal et al., 1997; Makagiansar et al., 2001; Sinaga et al., 2002) . Using this novel assay, the optimization of HAV peptides as well as the exploration of other active sequences in E-cadherin are now under investigation.
In conclusion, we have established a novel adhesion assay based on the homotypic adhesion of Caco-2 single cells to attached cells. The predominant involvement of E-cadherin was confirmed. Therefore, this assay can be used to evaluate the activities of compounds of interest, including mAb, peptides, or peptidomimetics, in modulating the E-cadherin-mediated cell-cell adhesion in the context of live cells. It was also suggested that the HAV motif in the EC1 domain of E-cadherin is at least in part involved in E-cadherin-mediated cell-cell adhesion. The concept of the present adhesion assay may be applicable to other cell lines such as MDCK cells and also to heterotypic adhesion between different species-originated cells.
